Home › Research › Biomarkers
Plasma neurofilament light reflects more severe manifestation of Alzheimer's disease in men
Xiaoqin Cheng, Zhenghong Wang, Kun He, Yingfeng Xia, Ying Wang, Qihao Guo, Fang Xie, Peng Yuan. Molecular psychiatry, 2025-08-12
Topic: Plasma and spinal-fluid biomarkers
Plain-language summary
Plasma neurofilament light (NfL) protein is a promising non-invasive biomarker for detecting neuronal damage in Alzheimer's disease (AD). However, its clinical utility is limited by the lack of standardized threshold values. Sex is an important factor that should be considered when setting these thresholds, but only a few studies have examined sex differences in plasma NfL levels in AD, with inconsistent findings. Even fewer have explored whether sex influences the relationship between plasma NfL levels and disease severity. To investigate this, we first analyzed data from 860 participants in the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. Linear regression models were used to assess sex differences in the correlation between plasma NfL levels, cognitive deficits, and neuroimaging metrics. A Cox model with bootstrap resampling was used to evaluate sex differences in dementia risk, calculating the hazard ratio for men versus women for a given increase in plasma NfL. Our results showed that, compared to women, men with higher plasma NfL levels exhibited more severe cognitive defects and brain hypometabolism, along with smaller hippocampal volume. These findings were validated using data from 619 participants in the Chinese Preclinical Alzheimer's Disease Study (C-PAS) cohort and 86 participants from a publicly available dataset. In addition, we found that increase in plasma NfL levels were predictive of faster cognitive decline and a higher likelihood of AD progression in men compared to women. In conclusion, sex differences influence the relationship between plasma NfL levels and AD symptoms. Men exhibit greater cognitive and neuropathological defects with rising plasma NfL levels, underscoring the need for considering sex when using NfL as a biomarker for neuronal damage in AD.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Cheng, X., Wang, Z., He, K., Xia, Y., Wang, Y., Guo, Q., et al. (2025). Plasma neurofilament light reflects more severe manifestation of Alzheimer's disease in men. Molecular psychiatry. https://doi.org/10.1038/s41380-025-03149-z
Vancouver
Cheng X, Wang Z, He K, Xia Y, Wang Y, Guo Q, et al. Plasma neurofilament light reflects more severe manifestation of Alzheimer's disease in men. Molecular psychiatry. 2025. doi:10.1038/s41380-025-03149-z. PMID: 40796698.
BibTeX
@article{cheng2025-40796698,
author = {Cheng, Xiaoqin and Wang, Zhenghong and He, Kun and Xia, Yingfeng and Wang, Ying and Guo, Qihao and Xie, Fang and Yuan, Peng},
title = {{Plasma neurofilament light reflects more severe manifestation of Alzheimer's disease in men}},
journal = {Molecular psychiatry},
year = {2025},
doi = {10.1038/s41380-025-03149-z},
pmid = {40796698},
url = {https://doi.org/10.1038/s41380-025-03149-z}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- A Cox model with bootstrap resampling was used to evaluate sex differences in dementia risk, calculating the hazard ratio for men versus women for a given increase in plasma NfL.
- Our results showed that, compared to women, men with higher plasma NfL levels exhibited more severe cognitive defects and brain hypometabolism, along with smaller hippocampal volume.
- These findings were validated using data from 619 participants in the Chinese Preclinical Alzheimer's Disease Study (C-PAS) cohort and 86 participants from a publicly available dataset.
- In addition, we found that increase in plasma NfL levels were predictive of faster cognitive decline and a higher likelihood of AD progression in men compared to women.
- In conclusion, sex differences influence the relationship between plasma NfL levels and AD symptoms.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants860
- Evidence strengthModerate
How this study scored 59/100
Published in a leading specialty journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 33 of the 56 points we could judge it on, which is 59 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Molecular psychiatry) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 860 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40796698) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 33 / 56 | Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 33 of the 56 points we could judge it on is 59 out of 100. |
| Total | 59 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Biomarkers from nearby years
Also tagged “p-tau217”
693 studies in the library carry the topic tag “p-tau217”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 693 tagged studies.